about
MicroRNA-145 targets YES and STAT1 in colon cancer cellsmiR-449 inhibits cell proliferation and is down-regulated in gastric cancerIntragenomic matching reveals a huge potential for miRNA-mediated regulation in plantsmicroRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancerProgrammed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cellsThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataIntegrative analysis of complex cancer genomics and clinical profiles using the cBioPortalIntegrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinomaOff-target effects dominate a large-scale RNAi screen for modulators of the TGF-β pathway and reveal microRNA regulation of TGFBR2Signatures of RNA binding proteins globally coupled to effective microRNA target sitescWords - systematic microRNA regulatory motif discovery from mRNA expression data.Identification and analysis of miRNAs in human breast cancer and teratoma samples using deep sequencingmiRMaid: a unified programming interface for microRNA data resourcesMicroRNA transfection and AGO-bound CLIP-seq data sets reveal distinct determinants of miRNA action.Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma.miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesisMicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells.The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line.Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplificationMolecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome.Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1.TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtypeValidation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.The molecular diversity of Luminal A breast tumors.An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer.Analysis of microRNA-target interactions across diverse cancer types.miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2.The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence.Genome-wide analysis of noncoding regulatory mutations in cancer.Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma.Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.Genomic landscape of lung adenocarcinoma in East AsiansCancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesisMutSpot: detection of non-coding mutation hotspots in cancer genomes
P50
Q21142669-34B8B57F-8105-4A27-AD47-46C42803DBF5Q21245766-CE77B742-14CD-4008-92DE-4ABD341EAC9FQ21563507-242820E1-DD98-4408-A153-F041AA7B4D1EQ24299080-FDEA7E80-EF3E-495B-9E5B-E0F972DC2AC7Q28256740-C1B2D251-5B6C-485F-BF5F-84B0581183E1Q28266682-43E97113-A488-4081-993F-64BDF63ADB53Q28288215-6F0C3921-B57E-463F-B2A3-6DAB8BFE7620Q28730850-6F1FAFA0-7F69-4E54-91FC-F0BEFAB3DA44Q28914776-0EF3408D-7069-48EB-8DDF-09EDBF5CD5CEQ28914779-C77FEE53-E7A2-4E86-B0A2-1159CD4A6E24Q30628865-1690AB3E-0C3E-4B3E-A5A1-AA311F9C44CAQ33464692-937ABB07-8DBC-4342-82CF-9913566CA689Q33523895-2FA90FB6-A397-4C89-BAB3-2FD7A370AE46Q33841641-26771672-4F89-47B4-B952-02E4CC662A68Q33938849-526D595E-62C8-4A18-A1CC-0E2DE6691625Q34221665-770F708C-4DC2-4239-B319-8F45950180A0Q34301072-13558EE0-FB89-47B6-A6CC-444E33F92FC3Q34976601-9826FD68-4145-4000-9A03-0C1277A1EDD2Q35050599-9B0C680A-693A-458E-B3E2-973B669FDEB7Q35152557-BBB61BF4-109B-4998-A8AE-42B9D54E6E03Q35227751-4FCDA15C-D10D-4BA0-A673-189E9C6EA00EQ35667690-8E8CEF45-5204-493D-B8BF-29B600FCB8EAQ36716606-854DA129-6368-4374-B010-0FEC029FAF01Q37298868-4DCB6A7A-56D1-4449-829F-545A0CB13715Q37399332-2B41F4ED-4967-4A67-832E-9E5CD2CD4D8BQ37542249-73C03DCF-1A42-40FE-BD2D-7EB62BBECCFAQ38690739-6AC34368-3E45-49CC-B8C6-7BB09B49FE99Q38989592-61DAB672-8103-4882-8D57-D8B59C03D598Q41020319-4720AE52-41FA-4048-A51B-4C8C9D89DA8DQ41842692-ED98B610-16C3-4E72-A940-CB1A0C5CCFECQ47787176-F54625DE-0638-44F3-8B09-13923B63B0D8Q52691469-A13E456A-BECB-4BC8-BC79-8E843722ED20Q89519134-F537546E-5B64-42DA-9027-55E68C68FAD4Q92647495-D3F7B84D-FEAA-46A1-B08F-9CE78056EBA4Q96576018-4156198D-621C-4305-89AC-5FB4CCCFC92F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anders Jacobsen
@ast
Anders Jacobsen
@en
Anders Jacobsen
@es
Anders Jacobsen
@nl
أندرس ياكوبسن
@ar
type
label
Anders Jacobsen
@ast
Anders Jacobsen
@en
Anders Jacobsen
@es
Anders Jacobsen
@nl
أندرس ياكوبسن
@ar
prefLabel
Anders Jacobsen
@ast
Anders Jacobsen
@en
Anders Jacobsen
@es
Anders Jacobsen
@nl
أندرس ياكوبسن
@ar
P1053
K-1081-2013
P106
P21
P31
P3829
P496
0000-0001-6847-4980